Trust Co. of Oklahoma Sells 162 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Trust Co. of Oklahoma reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 28.5% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 406 shares of the healthcare conglomerate’s stock after selling 162 shares during the period. Trust Co. of Oklahoma’s holdings in UnitedHealth Group were worth $201,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Tealwood Asset Management Inc. boosted its position in shares of UnitedHealth Group by 0.4% during the fourth quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock valued at $2,626,000 after buying an additional 19 shares during the last quarter. Atlas Private Wealth Advisors grew its holdings in UnitedHealth Group by 1.1% during the 4th quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock valued at $923,000 after buying an additional 19 shares in the last quarter. Prentice Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 0.8% in the 4th quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock worth $1,235,000 after purchasing an additional 19 shares during the period. Baker Avenue Asset Management LP lifted its stake in shares of UnitedHealth Group by 1.7% during the 3rd quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock worth $615,000 after acquiring an additional 20 shares during the last quarter. Finally, Granite Harbor Advisors Inc. raised its position in UnitedHealth Group by 2.9% during the 3rd quarter. Granite Harbor Advisors Inc. now owns 718 shares of the healthcare conglomerate’s stock valued at $362,000 after purchasing an additional 20 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Cantor Fitzgerald reissued an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research report on Wednesday, June 12th. JPMorgan Chase & Co. boosted their price target on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research note on Thursday, May 30th. Wells Fargo & Company lowered their target price on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research note on Monday, April 8th. Truist Financial restated a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Finally, Piper Sandler upped their target price on UnitedHealth Group from $566.00 to $571.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 17th. Three research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average price target of $579.74.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $489.90 on Thursday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.85. The business has a 50 day simple moving average of $498.64 and a two-hundred day simple moving average of $501.12. The stock has a market capitalization of $450.90 billion, a P/E ratio of 29.94, a PEG ratio of 1.47 and a beta of 0.60. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business’s revenue was up 8.6% compared to the same quarter last year. During the same period in the prior year, the business earned $6.26 earnings per share. As a group, analysts predict that UnitedHealth Group Incorporated will post 27.55 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.71%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date of this dividend was Monday, June 17th. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.